| Variables | Infant Death | ||||
| Group 1 N = 17 (%) | Group 2 N = 13 (%) | p-value | Adjusted RR | CI | |
| Mother WHO Stage |
|
|
|
|
|
| 1 | 2 (11.8) | 1 (7.7) |
|
|
|
| 2 | 7 (41.2) | 5 (38.5) | 0.004 | 3.22 | (2.25 - 6.00) |
| 3 | 5 (29.4) | 3 (23.1) |
|
|
|
| 4 | 3 (17.6) | 4 (30.8) |
|
| - |
| CD4 T Cells/mm3 |
|
|
|
|
|
| <350 | 9 (53.0) | 6 (46.1) | 0.005 | 2.81 | (1.20 - 4.11) |
| [350 - 500] | 4 (23.5) | 4 (30.8) | 0.009 | 0.06 | (0.38 - 3.44) |
| ≥500 | 4 (23.5) | 3 (23.1) | 0.724 | 0.11 | (0.56 - 1.99) |
| VL a Birth (copies/ml) |
|
|
|
|
|
| <50 | 11 (58.3) | 8 (61.7) |
|
| - |
| ≥50 | 6 (41.7) | 5 (38.3) |
|
| - |
| ART Initiation Moment |
|
|
|
|
|
| Before Pregnancy | 49 (44.1) | 32 (14.4) | 0.006 | 2.11 | (1.09 - 3.99) |
| During Pregnancy | 51 (45.9) | 166 (74.8) | 0.061 | 0.02 | (1.02 - 1.99) |
| During Delivery | 8 (7.2) | 24 (10.8) | 0.703 | 0.23 | (0.04 - 1.87) |
| HAART Regimens Used |
|
|
|
|
|
| 2INTI + 1INNTI | 9 (75.7) | 8 (86.0) | 0.640 | 0.61 | (0.39 - 3.19) |
| 2INTI + 1IP | 6 (18.9) | 5 (12.6) | 0.030 | 1.001 | (1.28 - 3.80) |
| 3INTI | 2 (5.4) | 0 (0.0) | 0.041 | 1.211 | (0.99 - 2.11) |
| Sex of Newborn |
|
|
|
|
|
| Male | 9 (55.9) | 7 (54.5) | 0.070 | 0.24 | (0.21 - 1.40) |
| Female | 8 (44.1) | 6 (45.5) | 0.821 | 0.20 | (0.40 - 1.90) |
| Infant Feeding |
|
|
|
|
|
| Formula Feeding | 8 (47.1) | 5 (38.5) | 0.171 | 0.07 | (0.23 - 1.96) |
| Breast Feeding | 9 (52.9) | 8 (61.5) |
|
|
|
| Infant HIV Status |
|
|
|
|
|
| Infected | 2 (11.8) | 3 (23.1) |
|
|
|
| Uninfected | 15 (88.2) | 10 (76.9) | 0.405 | 0.64 | (0.67 - 2.30) |